Literature DB >> 1327844

Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain.

A S Undie1, E Friedman.   

Abstract

We have previously reported that dopamine and the D1 receptor-selective agonist, SKF38393, stimulate the formation of inositol phosphates in rat brain slices (Undie and Friedman, 1990, J. Pharmacol. Exp. Ther. 253, 987). The present experiments were conducted to determine if actions at alpha-adrenoceptors or at serotonergic sites may contribute to, or interact with, the observed stimulation of phosphoinositide hydrolysis by dopamine receptor agonists. Rat striatal slices prelabeled with [3H]inositol were treated with up to 500 microM dopamine, norepinephrine, serotonin (5-HT), or the dopamine D1 receptor agonist, SKF38393, and accumulated inositol phosphates determined. The action of norepinephrine was dose-dependently blocked by the selective alpha 1-adrenoceptor antagonist, prazosin, but not by SCH23390. The actions of dopamine and SKF38393 were dose-dependently blocked by the dopamine D1 receptor antagonist, SCH23390, but not by prazosin. The effects of 5-HT were blocked by the nonselective 5-HT antagonist, methiotepin, the selective 5-HT2 antagonist, ketanserin, the mixed 5-HT2/5-HT1C antagonist, mianserin, and, with much less potency, by the selective 5-HT1C antagonist, mesulergine. On the contrary, the serotonin receptor antagonists did not block the response to SKF38393, and there was no dose-dependent blockade of the 5-HT response by SCH23390. These observations indicate that the actions of dopamine and SKF38393 in stimulating inositol phosphate formation are selectively mediated through a D1-like dopamine receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327844     DOI: 10.1016/0922-4106(92)90046-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens.

Authors:  S M Nicola; R C Malenka
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

3.  Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.

Authors:  Sarah K Leonard; Penelope Ferry-Leeper; Richard B Mailman
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

4.  Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.

Authors:  Jennie L Conroy; R Benjamin Free; David R Sibley
Journal:  ACS Chem Neurosci       Date:  2015-02-20       Impact factor: 4.418

5.  SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.

Authors:  Sang-Min Lee; Andrew Kant; Daniel Blake; Vishakantha Murthy; Kevin Boyd; Steven J Wyrick; Richard B Mailman
Journal:  Neuropharmacology       Date:  2014-06-12       Impact factor: 5.250

Review 6.  G protein-coupled receptor kinases as regulators of dopamine receptor functions.

Authors:  Eugenia V Gurevich; Raul R Gainetdinov; Vsevolod V Gurevich
Journal:  Pharmacol Res       Date:  2016-05-10       Impact factor: 7.658

7.  Dopaminergic regulation of progesterone receptors: brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats.

Authors:  E M Apostolakis; J Garai; C Fox; C L Smith; S J Watson; J H Clark; B W O'Malley
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Authors:  Asha Sahu; Kimberly R Tyeryar; Habiba O Vongtau; David R Sibley; Ashiwel S Undieh
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

Review 9.  Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?

Authors:  Sang-Min Lee; Yang Yang; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2014-07-22       Impact factor: 4.030

10.  Differential regulation of renal phospholipase C isoforms by catecholamines.

Authors:  P Y Yu; L D Asico; G M Eisner; P A Jose
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.